Concepedia

Nathalie Guragossian

NG

Statistics

Publications

5

Citations

126

H-Index

5

Active since

2015

Affiliations

Centre National de la Recherche Scientifique(Current)

Université Claude Bernard Lyon 1

Lyon College

Inserm

University of Münster

Nathalie Guragossian is an author at Centre National de la Recherche Scientifique specializing in medicinal chemistry, pharmacology, and cancer pharmacology.

ORCID

Publications per year

2015–2021

5

Publications

5

Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity

Attilio Di Pietro, Gustavo Jabor Gozzi, Zouhair Bouaziz et al. · Drug Design Development and Therapy · 2015 · 35 citations · Full text

, , +16

Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles

Diogo Henrique Kita, Nathalie Guragossian, Ingrid Fátima Zattoni et al. · Scientific Reports · 2021 · 31 citations · Full text

, , +16

New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2

Amanda do Rocio Andrade Pires, Florine Lecerf-Schmidt, Nathalie Guragossian et al. · European Journal of Medicinal Chemistry · 2016 · 30 citations · Full text

, , +10

Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2

Nathalie Guragossian, Billel Belhani, Alexis Moréno et al. · European Journal of Medicinal Chemistry · 2020 · 16 citations · Full text

, , +10

Structure-based design and profiling of novel 17β-HSD14 inhibitors

Florian Braun, Nicole Bertoletti, Gabriele Möller et al. · European Journal of Medicinal Chemistry · 2018 · 14 citations · Full text

, , +14

1–5 of 5